What Is the Future of Cell-Based Therapy for Acute Myocardial Infarction

Circ Res. 2017 Jan 20;120(2):252-255. doi: 10.1161/CIRCRESAHA.116.310340.

Authors

Bryon A Tompkins¹, Makoto Natsumeda¹, Wayne Balkan¹, Joshua M Hare²

Affiliations

¹ From The Interdisciplinary Stem Cell Institute (B.A.T., M.N., W.B., J.M.H.), Department of Surgery (B.A.T.), and Department of Medicine (W.B., J.M.H.), University of Miami Miller School of Medicine, FL.
² From The Interdisciplinary Stem Cell Institute (B.A.T., M.N., W.B., J.M.H.), Department of Surgery (B.A.T.), and Department of Medicine (W.B., J.M.H.), University of Miami Miller School of Medicine, FL. jhare@med.miami.edu.

No abstract available

Keywords: Editorials; clinical trial; death, sudden, cardiac; endothelial progenitor cells; myocardial infarction; stem cells.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Myocardial Infarction*
Stem Cell Transplantation*

Grants and funding